Esperion Therapeutics Inc (NAS:ESPR)
$ 2.12 0.12 (6%) Market Cap: 416.00 Mil Enterprise Value: 472.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 53/100

Esperion Therapeutics Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 10:15PM GMT
Release Date Price: $2.75 (-1.43%)
Jessica Fye JPMorgan Chase;Co;Analyst

&-

I'm a senior biotech analyst at JPMorgan, and we're continuing the Health Care conference today with Esperion. I'm joined upfront by the Company's CEO, Sheldon Koenig and he's going to have a presentation on the business and then we're going to go into Q&A. If you've got a question in the room, raise your hand, we'll get you a mike or you can submit questions to me via the portal and I will read them of the iPad up here. So with that, let me pass it over to Sheldon.

Sheldon Koenig Esperion Therapeutics
Inc. - President & CEO

Great. Thank you, Jess. And first of all on behalf of Esperion and the company. Thank you to JPMorgan for allowing us to have the opportunity to talk about Esperion. Really exciting business, we'll talk about that in a few seconds look forward to Q&A that you may have. So I think we're taking Q&A online and also in the room, there's a microphone that will be available in the room. So thank you again for your attention.

And forward-looking statement,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot